FluoSphera has been selected to the 5th cohort of IndieBio New York, the World's Biggest #biotech Accelerator, together with 9 other startups working for Human and Planetary #health ! 💊 🌎 indiebio.co/cohort/ibny05-… FONGIT @sosventures IndieBio Roux Lab Science Innovation Hub - UNIGE UNIGE_en

Yesterday evening, we celebrated the 15th anniversary of Venture Kick!🎂 FluoSphera was invited there and very proud to be one of the successful startups getting the kicks! Check it out 👇 FONGIT Science Innovation Hub - UNIGE Roux Lab Geneus IndieBio SOSV - Deep Tech for Human and Planetary Health iGEM Startups Venturelab BioAlps - Life Sciences Cluster 🇨🇭

Great news! FluoSphera has been selected as a Deep Tech Pioneer by Hello Tomorrow! Come and meet us at the Hello Tomorrow Global Summit in March 2023! 👉 hello-tomorrow.org/global-summit/… Science Innovation Hub - UNIGE IndieBio SOSV - Deep Tech for Human and Planetary Health Roux Lab FONGIT Université de Genève Faculty of Science | UNIGE Venturelab Geneus

Honored to be part of this great cohort IndieBio! Do not miss the Demo Day to see our technology! Registration below 👇 FONGIT Science Innovation Hub - UNIGE UNIGE_en Roux Lab ACCESS Geneva Facility iGEM Startups Geneus SOSV - Deep Tech for Human and Planetary Health

📸 Last week we hosted Start-up Day, where #biotech and #pharma leaders met #startups, with pitches from PDCTherapeutics, PROSION Therapeutics & FluoSphera. 🙏 Thanks to CSL Behring, Bristol Myers Squibb and Ferring Pharmaceuticals for meeting our upcoming companies! #CorporatePartnerships #ItHappenedatBiopôle

Very proud that Le Figaro Santé, one of the most famous French media, featured FluoSphera in an article and in a video interview with our CEO, Gregory Segala: lnkd.in/eF6KBD8Z FONGIT Science Innovation Hub - UNIGE SOSV - Deep Tech for Human and Planetary Health IndieBio Université de Genève Roux Lab iGEM Startups Venturelab

7️⃣February is IndieBio NY #5 online #demoday 🚀 Come meet our innovative companies in #agtech #altprotein #biotech #climatetech #foodtech #synbio #healthtech #microbiome #sustainability #planetaryhealth #builtbySOSV SOSV - Deep Tech for Human and Planetary Health #NY #NYC Register here: bit.ly/3Hz9YU0

We've made it! FluoSphera is selected in the TOP 50 of the W.A. DE VIGIER FOUNDATION Prize 2023!! 💪Watch our presentation, on February 23, during the Life Science/Biotech/Pharma session starting around 11 am! 🚀 FONGIT IndieBio SOSV - Deep Tech for Human and Planetary Health Venturelab Geneus BioAlps - Life Sciences Cluster 🇨🇭 Roux Lab Science Innovation Hub - UNIGE

Many thanks FONGIT for your constant support, in the daily life of FluoSphera but notably during this fundraising round! Grateful for that! 🙏 Roux Lab Science Innovation Hub - UNIGE Geneus SOSV - Deep Tech for Human and Planetary Health IndieBio UNIGE_en i-Teams

📢 If you missed the presentation of FluoSphera during the Demo Day at IndieBio New York, you can watch it by following this link: lnkd.in/eszXjNPE #drugdiscovery FONGIT SOSV - Deep Tech for Human and Planetary Health Roux Lab Science Innovation Hub - UNIGE Geneus ACCESS Geneva Facility Venturelab UNIGE_en BioAlps - Life Sciences Cluster 🇨🇭

FluoSphera is honored to welcome Jean-Pierre Pennacino, bringing outstanding financial expertise to the Board, CFO at MedAlliance Swiss Medical Technology; top management positions at companies listed on the SIX, NYSE, Nasdaq, and at PwC. FONGIT Science Innovation Hub - UNIGE Roux Lab SOSV - Deep Tech for Human and Planetary Health IndieBio BioAlps - Life Sciences Cluster 🇨🇭 UNIGE_en

💰CHF 100'000! This is the support FluoSphera received from the @Fongit Innovation Fund to develop our drug discovery technology!🚀 Thank you very much for trusting FluoSphera from the very beginning!🙏 Science Innovation Hub - UNIGE Roux Lab SOSV - Deep Tech for Human and Planetary Health IndieBio BioAlps - Life Sciences Cluster 🇨🇭 Venturelab SwissBiotech

Featured in the news of the SwissBiotech Association for getting a grant of CHF 1.1M from Innosuisse to partner with UNIGE_en and EPFL to develop our disruptive tech! Thank you! swissbiotech.org/listing/fluosp… Roux Lab ACCESS Geneva Facility Science Innovation Hub - UNIGE FONGIT SOSV - Deep Tech for Human and Planetary Health IndieBio iGEM Startups

Congratulations to RESI Boston Innovator’s Pitch Challenge (IPC) finalist, FluoSphera! CEO, Clelia Bourgoint, will pitch on 9/25. Each session includes a Q&A with active #investor judges. Apply by WEDNESDAY, AUGUST 14: form.jotform.com/241214875257156

Let’s give a huge round of applause for the newcomers! Celebrating the rising stars who have earned their place in this year’s TOP 100 Swiss Startup Ranking. Discover: @AisotHQ Antefil Composite Tech Apheros Bottneuro BTRY calvinrisk CustomSurg deskbird DPHI Space DuoKey

🔊BREAKING NEWS: FluoSphera entered the prestigious TOP100 Swiss Startups Ranking, hitting the 39th position overall, and ranked as the 10th Life Sciences Startups! A Huge thank you to our team and supporters! #TOP100SSU FONGIT Science Innovation Hub - UNIGE Roux Lab iGEM Startups Faculty of Science | UNIGE

🚨Spirochrome and FluoSphera new collaboration! Our PKmem probes for gentle plasma membrane imaging meet Fluosphera's highly innovative encapsulated cancer spheroids technology! Staining lasted over 72 hours without (photo)toxicity or bleaching, improving overall data quality

Proud to be ranked among the most promising MedTech startups in Switzerland! 🚀 Roux Lab FONGIT Science Innovation Hub - UNIGE Faculty of Science | UNIGE UNIGE_en ACCESS Geneva Facility iGEM Startups IndieBio SOSV - Deep Tech for Human and Planetary Health

📢 FluoSphera Expands Platform to Support Advances in Antibody-Drug Conjugates (ADCs) With FluoSphera's advanced platform, ADC developers can now gain critical insights into how their treatments will behave in the human body before clinical trials. prnewswire.com/news-releases/…

Our collaboration with FluoSphera 2nd episode: 2 types of cancer spheroids (HER2 positive and HER2 negative) were color coded with our PKmem probes and co-cultured in microcavity plates. Live cell imaging beautifully captures the progressive binding of trastuzumab-FITC (anti